EP2922576
Aðferðir við að gefa og meta lyf sem fjarlægja köfnunarefni til meðhöndlunar á lifrarheilakvilla
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.11.2013EP published:
8.11.2017EP application number:
13857455.3
EP translation filed:
1.2.2018Grant published:
15.2.2018EPO information:
European Patent Register
Max expiry date:
20.11.2033Expiry date:
20.11.2019
Title:
METHODS OF ADMINISTERING AND EVALUATING NITROGEN SCAVENGING DRUGS FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY
Timeline
Today
21.11.2013EP application
8.11.2017EP Publication
1.2.2018Translation submitted
15.2.2018Registration published
20.11.2019Expires
Owner
Name:
Horizon Therapeutics, LLCAddress:
150 S. Saunders Rd., 60045, Lake Forest, IL, US
Inventor
Name:
SCHARSCHMIDT, BruceAddress:
San Francisco, CA, US
Name:
MOKHTARANI, MasoudAddress:
Walnut Creek, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261728967 PDate:
21.11.2012Country:
US
Number:
201361759292 PDate:
31.1.2013Country:
US
Classification
Categories:
A61K 49/00, A61K 31/19, A61P 25/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 18.1.2018
Expires: 20.11.2018
Payer: Sigurjónsson & Thor ehf.
Number: 6
Paid: 31.10.2018
Expires: 20.11.2019
Payer: Sigurjónsson & Thor ehf.